From our AOL folder...Subject: Re: albumin recallDate: Tue, Feb 17, 1998 15:03 ESTFrom: JGCFP1988Message-id: <19980217200301.PAA29193@ladder02.news.aol.com>In the near future there will be the first cases described of the transmission of CJD by human albumin. The cases occurred in China and the source was infected albumin from Europe. Biotime ( BTIM ) is set to file a NDA for a new 100% safe, effective and synthetic volume expander. Very interesting story. ABT is the big Pharma partner is the US. ===========Subject: albumin recallDate: Sat, Jan 24, 1998 10:16 ESTFrom: DavdennyMessage-id: <19980124151600.KAA15690@ladder02.news.aol.com>I was reading another board this morning (BTIM, a very good board BTW) that referenced a recall of albumin due to a possible connection with BSE/CJD cases. Does anyone on this board know anything about this? (I couldn't think of a better place to inquire.)tks in advance==========Subject: Re: NewsDate: Fri, Nov 28, 1997 16:18 ESTFrom: Jonatha546Message-id: <19971128211801.QAA21206@ladder01.news.aol.com>I heard that Vimrex/Baxter's Isolex cell-separating device for bone marrow purging was rejected by FDA. I WONDER WHY WE HAVEN'T SEEN ANY OFFICIAL PRESS RELEASE FROM EITHER PARTY.===========Subject: ...relationship w/CERS.Date: Sat, Nov 22, 1997 20:26 ESTFrom: KnetMessage-id: <19971123012600.UAA26776@ladder02.news.aol.com>...the relationship w/CERS good be a blockbuster for both firms...do cross referch'g w/both firms...you will see that w/in a qutr. or two...it could be expl've....IMO....==========Subject: RE: PRICE DROPDate: Sat, Nov 22, 1997 14:47 ESTFrom: Esteban 65Message-id: <19971122194700.OAA26310@ladder01.news.aol.com>For what it is worth I agree that Baxt outlook is strong, but emphasize that it likely will have NOTHING to do with the blood substitutes mkt. Since we are seeing such products go belly up across all companies that sponsor them, think its a pretty fair bet that, as historically has been the case, Blood subs will remain an unfullfilled dream. Also, demand for blood & related products in the U.S. is actually declining slightly, and a whole slew ofproducts and processes about to hit the mkt likely will create added surplus (screening, cryopreservation,etc.). Again, Baxt is a good horse for the long term, but not for the reasons I see on this board.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, An